Recruiting

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(52 sites)

United States

Research Site, Orange, California

Research Site, Palo Alto, California

Research Site, Santa Rosa, California

Research Site, Louisville, Kentucky

Research Site, Commack, New York

Research Site, Providence, Rhode Island

Research Site, Houston, Texas

Australia

Research Site, Melbourne

Research Site, Murdoch

Research Site, Randwick

Canada

Research Site, Kingston, Ontario

Research Site, Toronto, Ontario

Research Site, Montreal, Quebec

Research Site, Sherbrooke, Quebec

China

Research Site, Changsha

Research Site, Chengdu

Georgia

Research Site, Tbilisi

Japan

Research Site, Chūōku

Research Site, Kashiwa

Research Site, Kitaadachi-gun

Research Site, Kōtoku

Research Site, Nagoya

Research Site, Osakasayama-shi

Malaysia

Research Site, George Town

Research Site, Johor Bahru

Research Site, Kuala Lumpur

Research Site, Kuala Selangor

Research Site, Kuching

Moldova

Research Site, Chisinau

Poland

Research Site, Krakow

Research Site, Warsaw

Singapore

Research Site, Bukit Merah

Research Site, Singapore

South Korea

Research Site, Gyeonggi-do

Research Site, Seoul

Spain

Research Site, Barcelona

Research Site, Madrid

Taiwan

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan

Research Site, Taipei

Research Site, Taoyuan District

United Kingdom

Research Site, Glasgow

Research Site, Leeds

Research Site, London

Research Site, Oxford